Capricor Therapeutics (CAPR) EPS (Weighted Average and Diluted): 2016-2025
Historic EPS (Weighted Average and Diluted) for Capricor Therapeutics (CAPR) over the last 4 years, with Sep 2025 value amounting to -$0.54.
- Capricor Therapeutics' EPS (Weighted Average and Diluted) fell 42.11% to -$0.54 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.56, marking a year-over-year decrease of 52.94%. This contributed to the annual value of -$1.15 for FY2024, which is 38.55% down from last year.
- According to the latest figures from Q3 2025, Capricor Therapeutics' EPS (Weighted Average and Diluted) is -$0.54, which was down 1.89% from -$0.53 recorded in Q2 2025.
- Capricor Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.02 during Q4 2023, with a 5-year trough of -$0.54 in Q3 2025.
- In the last 3 years, Capricor Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.31 in 2024 and averaged -$0.31.
- In the last 5 years, Capricor Therapeutics' EPS (Weighted Average and Diluted) skyrocketed by 106.45% in 2023 and then tumbled by 650.00% in 2024.
- Quarterly analysis of 5 years shows Capricor Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.26 in 2021, then fell by 19.23% to -$0.31 in 2022, then spiked by 106.45% to $0.02 in 2023, then tumbled by 650.00% to -$0.11 in 2024, then plummeted by 42.11% to -$0.54 in 2025.
- Its last three reported values are -$0.54 in Q3 2025, -$0.53 for Q2 2025, and -$0.11 during Q4 2024.